Here at the Lehigh Center for Clinical Research, we are working to develop the medications and treatments of tomorrow with the research we do today. This crucial and exciting work depends on volunteers for our many different clinical studies, where we test and learn more about medications that are in their final stages of development.…
Researchers in Japan have uncovered a new potential cause of depression that may aid in the development of new medications that better treat the mood disorder that affects over 300 million people worldwide.
A new study suggests that regular exercise can reduce instances of poor mental health. Researchers concluded that all exercise types contributed to better mental health among participants, but that team sports, cycling and aerobic and gym activities had the largest positive effect.
Early-onset Alzheimer’s is a form of dementia that occurs in individuals younger than the age of 65. Of all the people that are affected by Alzheimer’s disease, only five percent develop symptoms before age 65. While this may seem like an insignificant number, over 4 million Americans are currently battling Alzheimer’s, meaning at least 200,000…
While commonly used as an anesthetic and pain reliever, Ketamine is likely more famous as an illicit party drug, better known as K or Special K, sometimes referred to as cat or horse tranquilizers. Partially because of this negative association, many are skeptical of its viability as a valid medical treatment for depression, a use several doctors and researchers have been advocating for years.
A recent study conducted by researchers at Iowa State University may have identified the missing link between a metabolic gene and Alzheimer’s Disease, a connection that has eluded scientists for years. Led by Auriel Willette, an assistant professor of food science and human nutrition, the study concluded that family history can alter the behavior of TOMM40, explaining inconsistencies in previous research.